Global X-ray Mammography Imaging Systems Market, Forecast to 2022

Monday, August 6, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, August 6, 2018 /PRNewswire/ -- Evaluating Growth Patterns and Opportunities Across X-ray Mammography SetsOver

the last 20 years, hospitals and imaging centers in developed economies have adopted X-ray mammography equipment to screen and diagnose breast cancer.This has led to significant reduction in mortality and prompted emerging countries to invest in population-based,
organized screening.Download the full report: Significant investments in mammography technology have paved the way for radiation safety, patient comfort, and 3D imaging that provides precise tumor detection.Market measurements—revenue and year-over-year growth rate by region and segment—are analyzed for 2015 to 2016 and forecast until 2022.Pricing range and growth trend by sub-segment is discussed for the base year.An extensive list of manufacturers in the X-ray mammography space to watch out for in 2017 is also provided.X-ray mammography is the gold standard for breast cancer detection.Due to the rising incidence of breast cancer, organized population-based screening programs are carried out in Western countries at a 1-to-3-year screening interval, depending on country policies.Starting in early 1990, the countries have witnessed a significant decrease in mortality.Mammography was not considered patient friendly due to discomforts caused, possible false positives, overlooked tumors and the potential radiation exposure.However, with innovations in technology focusing on microcalcification, sensitivity, specificity, use in dense breast tissue patients, most western countries have switched to full-field digital mammography. However, reimbursements deter the adoption of digital breast tomosynthesis for screening programsWith the advent of private hospitals and favorable reimbursement health insurance, there is more demand for patient safety and quality of technologies, reduced hospitalization and reduction in overall healthcare costs in Asia-Pacific.Globally, countries are placing emphasis on early detection of breast cancer safety and investing in screening programs.Business models focusing on managed services, pay per use , sharing services, integrated workflow and automation are changing the landscape of the mammography procurement.These factors determine the growth of the mammography market.Strategies, growth analyses, competitive landscape, and future focus are discussed for vendors, such as GE Healthcare, Siemens Healthineers, Hologic, IMS, Planmed, Carestream, Agfa, Fujifilm, Allengers, Cura Healthcare, and Konica Minolta, among others. The base year for the study is 2017; the historic years are 2015 and 2016; the forecast period is from 2018 to 2022.Research ScopeThis study aims to analyze and forecast the X-ray Mammography Imaging Systems market in North America (US and Canada), Europe, and Asia-Pacific for 2017. Market trends analyzed include utilization of mammography systems, breast care statistics, mammography procedure volume analysis, and clinical layout of breast care in countries presented in research scope, growth indicators, market adoption and penetration, factors influencing RoI, critical unmet needs and potential game-changing strategy, growth opportunities for X-ray mammography, technology trends driving X-ray mammography growth, future prospects, product profile, competitive structure, market metrics market share, revenues, and strategy.Regions Covered:• North America (the United States and Canada)• Europe: Western Europe (Germany, the United Kingdom, Italy, France, Spain, Benelux, Scandinavia); Eastern Europe (Hungary, Poland and Romania)• Asia-Pacific (China, India and Japan )Analyses by analog, computed, 2D digital, 2D digital to DBT upgrade and digital breast tomosynthesis are provided for the three regions.Download the full report: About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Email: Tel: +1 (718) 213 4904 Website:

Cision View original content:

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store